Clinical Updates & Insights

Share
Print

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

Stay Informed
Get the latest information on MSK’s cancer treatments and research sent straight to your inbox with our monthly clinical updates e-newsletter OncoNotes.
Newsletter Sign Up

Manage Preferences

184 Clinical Updates found

Clinical Update

Hepatic Arterial Infusion Converts “Unresectable” Colorectal Liver Mets

The advent of hepatic arterial infusion chemotherapy (HAI) for treating patients with resectable colorectal liver metastases has increased survival outcomes to previously unimaginable levels. However, questions remain about the effectiveness of its use in patients with initially unresectable colorectal liver metastases.

  • Friday, August 2, 2019

Clinical Update

New Molecular Signatures of High-Risk Neuroblastoma

High-risk neuroblastoma cells harbor distinguishing molecular signatures, according to recent research.

  • Friday, August 2, 2019

Clinical Update

Chemotherapy Reduces Seizures in Low-Grade Oligodendroglioma

Temozolomide chemotherapy reduced seizures in 90 percent of patients with World Health Organization (WHO) grade 2 oligodendroglioma and tumor-related epilepsy.

  • Friday, June 28, 2019

Clinical Update

Minimizing Cardiotoxicities of Contemporary Breast Cancer Treatments

In our recently published review paper we provide a comprehensive update on the cardiotoxicities associated with contemporary breast cancer treatment and the latest strategies for their prevention, detection, and management.

  • Friday, June 28, 2019

Clinical Update

Nasal Cavity Cancer: Radiation Is a Valid Option for Patients Refusing Surgery

Radiation is a feasible option for patients with squamous cell carcinoma of the anterior nasal cavity mucosa who refuse rhinectomy, according to our recent research.

  • Friday, June 7, 2019

Clinical Update

Tackling Lymphedema: New Insights from MSK’s Dedicated Lab

New insights into the pathophysiology of lymphedema are providing targets for future treatment interventions to cure and prevent the disease, according to our recent research.

  • Friday, June 7, 2019

Clinical Update

Less Is Better: Promising Results for Reduced-Dose Radiation Therapy in High-Risk Pediatric Neuroblastoma

Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial.

  • Monday, May 13, 2019

Clinical Update

Less Risk of Femoral Fracture with Intensity-Modulated Radiation Therapy for Thigh and Groin Sarcoma

Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation.

  • Monday, May 13, 2019

Clinical Update

Surgery Is Critical in Advanced Testicular Cancer

Resection of all residual disease after salvage chemotherapy offers the best chance for a cure for patients with refractory or relapsed advanced testicular cancer, according to the results of our recent retrospective study.

  • Friday, April 5, 2019

Clinical Update

Deep Learning with MRI-Radiomics Improves Survival Prediction in Glioblastoma

Incorporating radiomics with methyl guanine methyl transferase (MGMT) status can more accurately stratify glioblastoma patients into groups with different survival risks compared to using either prediction tool in isolation.

  • Thursday, April 4, 2019